Combine Solicitation – 65– Whole Blood & Blood Products
Notice Type: Combine Solicitation
Posted Date:
Office Address:
Subject: 65-- Whole Blood & Blood Products
Classification Code: 65 - Medical, dental & veterinary equipment & supplies
Solicitation Number: VA24815Q0634
Contact:
Setaside: N/AN/A
Place of Performance (address):
Place of Performance (zipcode): 32827-7403
Place of Performance Country:
Description:
Orlando VAMC
This is a combined synopsis/solicitation for commodities (
(iii) This combined synopsis solicitation RFQ and the provisions and clauses incorporated are those in effect through Federal Acquisition Circular 2005-80 (
(iv) The combined synopsis solicitation is UNRESTRICTED. NAICS is 621991. Business size standard is 500 employees.
(v) This combined synopsis solicitation is for the purchase of Whole Blood and Blood Products. See schedule below for more information.
(vi) Description of Requirement as follows:
BLOOD BANK/WHOLE BLOOD AND BLOOD PRODUCTS
SUPPLIES/SERVICES
Whole blood and blood products shall be furnished to the
(PROJECTED) BASE PERIOD OF PERFORMANCE: TBD
Item No
Item Description Extended Qty Unit
1 300 ML Transfer Bags 1 Ea
2
3 ABO RH Cord 1 Ea
4 ABO RH Newborn 1 Ea
5 Acid Elution 1 Ea
6 Adsorption 1 Ea
7 After Hour's Expense 1 Ea
8 Annual follow-up blood test 1 Ea
9 Antibody Screen (Indirect Coombs) 1 Ea
10 Antigens/Patient Phenotyping 1 Ea
11 Apheresis kit 1 Ea
12 AUTO PLASMA EXCH > 4 HRS 1 Ea
13 Auto/Direct Handling Waste 1 Ea
14 Autologous Fee 1 Ea
15 Autologous Leuko reduced Red Blood Cells 1 Ea
16 Autologous Red Blood Cells 1 Ea
17 Autologous Service Charge 1 Ea
18 Autologous Whole Blood 1 Ea
19 Autologous Whole Blood Wastage 1 Ea
20 Cancellation / Set Up Fee (Bedside Phlebotomy) 1 Ea
21 CD34 Product 1 Ea
22 Chloroquine treatment - Bg antigens 1 Ea
23 CMV Test 1 Ea
24 Computer Antigen Search 1 Ea
25 Cryoprecipitate (Single) 20 Ea
26 Deglycerolization Fee 1 Ea
27 Direct Antiglobulin Test (Direct Coombs) 1 Ea
28 Dithiotreitol Treatment (includes panel) 1 Ea
29 Enzyme Treatment 1 Ea
30 Fetal Screen 1 Ea
31 Freeze & Degly. Fee 1 Ea
32 Freeze Fee 1 Ea
33 Fresh Blood Fee (5 or less days from collection) 1 Ea
34 Fresh Frozen Plasma 275 Ea
35 Fresh Frozen Plasma (Cryo removed) 1 Ea
36 Frozen Plasma - 24Hr. 1 Ea
37 GRANULOCYTE PLT PHERESIS 2 Ea
38 HBsAg ( Hep.B suface antigen) 1 Ea
39 HLA Antibody Screen 1 Ea
40 HLA B27 Typing 1 Ea
41 HLA Matched Fee 1 Ea
42 HLA Tissue Typing 1 Ea
43 IgG Dissociation 1 Ea
44 Irradiation Fee (1 unit) 1 Ea
45 Klehauer - Betke 1 Ea
46 Lookback 1 Ea
47 LUI Elution 1 Ea
48 MISC COST FOR FEE TRANSPORTATION, CMV, IRRADIATED UNITS,ETC 100 Ea
49 Nat Testing 1 Ea
50 Neonate Fresh Frozen Plasma 1 Ea
51 Neutralization P1 or Lewis (includes panel) 1 Ea
52 ONLY SETUP/CANCELLATION 1 Ea
53 PB Stem Cells 1 Ea
54 Platelet (Volume Reduction Fee) 1 Ea
55 Platelet Pheresis Single Donor (non LR) 160 Ea
56 Platelet Wash Fee 1 Ea
57 Pooling Fee (Sterile Connection) 1 Ea
58 Pooling Fee for 10 Cryo 1 Ea
59 Pre - Pooled Cryo (10) - excludes pooling fee 1 Ea
60 Pre - Pooled Platelets LR (5) - excludes pooling fee 1 Ea
61 Pre Warm Preparation 1 Ea
62 Price adjustments 1 Ea
63 Professional Fee 1 Ea
64 Rare Unit fee 1 Ea
65 RBC Antibody Titer 1 Ea
66 RBC Antibody Workup 1 Ea
67 RBC Antigen Typing 1 Ea
68 RBC Cell Separation 1 Ea
69 RBC Crossmatch (each additional unit) 1 Ea
70 RBC DEPLETION 1 Ea
71 RBC lacking high incidence antigen fee 1 Ea
72
73 RBC Wash Fee 1 Ea
74 REC.PLAS FROZEN 0-24 1 Ea
75 Red Blood Cells - LR 1280 Ea
76 Red Blood Cells - NLR 3 Ea
77 Reference Stat Fee 1 Ea
78 Repeat infectious disease test 1 Ea
79 Research leukocyte collection 1 Ea
80 Research whole blood collection 1 Ea
81 Sickle Cell Screen 1 Ea
82 Single Bag CPDA 1 Ea
83 Single Donor Plateletpheresis (leukoreduced) 1 Ea
84 Single Donor Plateletpheresis (leukoreduced) <3 2 Ea
85 SOURCE LEUKOCYTE 1 Ea
86 Special Delivery/PickUp 1 Ea
87 Stat Processing Fee 1 Ea
88 Stem Cell Collection 1 Ea
89 Sterile Doc Quad Pack 1 Ea
90 Thaw Fee 1 Ea
91 Therapeutic Leukodepletion 1 Ea
92 THERAPEUTIC PHLEBOTOMY (BEDSIDE) 1 Ea
93 Therapeutic Phlebotomy (
94 Therapeutic Plasma Exchange 1 Ea
95 Therapeutic Platelet Depletion 1 Ea
96 Transfusion Reaction Work Up 1 Ea
97 Type and Screen 1 Ea
98 Whole Blood LR 3 Ea
99 Whole Blood Platelet 1 Ea
100 Whole Blood Platelet (leukoreduced) SINGLE LR 1 Ea
101 Cryo Poor Plasma 1 Ea
102 Cryoprecipitate Processing 1 Ea
103 Cryoprecipitate Wastage 1 Ea
104 Volume reduced Component Fee 1 Ea
105 Hemoglobin S Testing 1 Ea
106 Leukoreduced Platelet Pheresis Bacti QC 1 Ea
107 Leukoreduced Platelet Pheresis-Divided Wastage 3 Ea
108 Pheresis Charge-After Hours 3 Ea
109 Pheresis Transportation 2 Ea
110 Platelet Antibody Screen ONLY 1 Ea
111 Platelet Crossmatch 9 Ea
112 Platelet Crossmatch PM 1 Ea
113 Platelet Pheresis Divided LR/BACTI QC 1 Ea
114 Prosoba Column 1 Ea
115 Pheresis per hour charge over 3 hours 1 Ea
116 Photopheresis Procedure 1 Ea
117
118 Rare Donor Search Thru ARDP 1 Ea
119 RBC Genotype 1 Ea
120 STAT Charge for Pheresis 2 hr 1 Ea
121 STAT Charge for Pheresis 4 hr 1 Ea
122 STAT Reference Workup 1 Ea
123 Ther Pher Cancel 1 Ea
124 Rare Unit Fee 1 Ea
125 Therapeutic Pheresis Fee Delay 3 Ea
126 Therapeutic Pheresis Red Cell Exchange 1 Ea
127 Therapeutic Pheresis-Plasma Exchange 14 Ea
128 Thereapeutic Pheresis-LDL 8 Ea
129 Whole Blood Derived Platelets 1 Ea
130 Cell Washing Procedure 1 Ea
131 Fetal Blood Screening 1 Ea
132 Reference Lab Workup, Extended 1 Ea
133
SECTION I - WHOLE BLOOD AND BLOOD COMPONENTS
Whole blood and blood components, in suitable containers are to be delivered F.O.B. destination within consignee's premises, to
A. COLLECTION, PROCESS AND TYPING OF BLOOD
Blood shall be typed for ABO and Rh antigens and screened for red cell antibodies in accordance with methods recommended in the current edition of Standards for Blood Banks and Transfusion Services and the Technical Manual of the
1. All blood is to be collected in a closed system under aseptic conditions and shall be processed in appropriate solutions and the container so labeled. The label shall also bear the expiration date of the contents which shall not exceed 21 days from date of collection if collected in CPD, 35 days from date of collection if collected in CPDA-1, or 42 days if AS-1 is used as an additive.
2. All blood supplied shall be grossly free of hemolysis, excessive chyle and clots. All unsatisfactory units (broken FFP, clots in red cells, etc.) shall be returned and full credit given to VA.
3. All blood supplied must be leukocytes reduced.
4. All blood must be labeled according to the
B. PACKAGING AND MARKING
1. Blood shall be labeled as to A, B, O and Rh type. Type A Rh negative, A Rh positive, O Rh negative, and O Rh positive must have been drawn from donor not more than five (5) days before date on which purchase order is filled. Types such as AB Rh positive, AB Rh negative, B Rh negative and B Rh positive shall be supplied as fresh as possible but not over fifteen (15) days old if blood is collected in CPDA-1. These time limits may be adjusted if a system for exchange on credit is provided which minimizes or precludes losses due to outdating.
2. When platelets shall be separated from donor blood, the blood may be at room temperature up to eight (8) hours. If platelets are not separated, the blood shall be refrigerated immediately after bleeding between 1o and 6o C with fluctuation of no more than 2o C within this range. Freezing must be avoided at all times. If public transportation of the blood is necessary, it shall be transported in clean shipping containers provided with refrigeration sufficient to hold the blood at 1-10o C if it has been precooled. If the blood has not been cooled, the shipping containers shall provide sufficient refrigeration to bring the temperature toward 1-10o C, preferably, 1-6o while in transit.
3. Control of blood inventory management shall be handled by the compatibility testing contractor.
C. SPECIALIZED SERVICES
The contractor agrees to provide specialized services such as reference lab testing, confirmatory testing, inventory control, irradiation of blood components, testing of all platelet components for bacterial contamination, HLA matched blood components, platelet cross matching, donor-patient testing and other testing and services, as needed. These services are provided for special patients in need and arrangements shall be made on a case by case basis.
D. DELIVERIES OR PERFORMANCE
1. The blood shall be delivered as specified within twenty-four (24) hours following request. Emergency requirements are to be available twenty-four (24) hours a day and seven (7) days a week, for pickup within 30-60 minutes from the time requested or to be delivered at the expense of VA. Empty containers, blood, and equipment being returned for credit shall be returned at contractor's expense.
2. All blood picked up at the
3. Compatibility control of blood inventory management shall be handled by the compatibility testing contractor.
E. LISCENSE: The contractor shall possess an unrevoked U.S. License which is issued by the Director,
F. INTERSTATE SHIPMENT: If interstate shipment of blood or blood component is involved, the contractor must submit prior to award a statement that such approval has been authorized under Section 251 of the Public Health Service Act, as amended 42 USC Section 262.
G. CERTIFICATION: By signing this contract, the contractor certifies that he/she is in compliance and will remain in compliance with the requirements outlined with respect to donors, containers, and delivery of blood products for the duration of the contract.
H. BLOOD DONATION: The contractor shall provide the VA only with 100% "volunteer donor" blood in accordance with
I. DONOR LIST:
1. The contractor must maintain readily available blood donor lists including names, addresses and social security numbers. Such lists shall indicate whether and on what date blood of a particular donor was furnished to the VA under this contract period.
2. Donor selection must be in accordance with criteria established by the
J. ORDERING:
Control of blood inventory management shall be handled by the compatibility testing contractor. Additional emergency requirements may be placed and the shipper shall arrange for delivery in one hour or less (including orders during evenings and nights). If outside delivery (taxi) is used, VA will provide payment for the transportation in the instances of emergency requirements shipped other than scheduled ship dates.
K. INSPECTION OF CONTRACTOR'S FACILITIES:
The government reserves the right to thoroughly inspect and investigate the establishment and facilities and other qualifications of any contractor or to reject any proposal regardless of price.
L. NOTIFICATION REQUIREMENTS
1. In the event the Contractor receives information indicating that the blood and blood products may adversely affect a transfusion recipient, the Contractor shall notify the Medical Director or designee of the
2. In the event of a new testing requirement or regulation regarding the donated blood or blood products supplied to
3. CONTRACTOR is responsible for the following Look back requirements:
4. Look back Procedure.
CONTRACTOR shall perform its Look back responsibilities in compliance with applicable provisions of law, including, specifically, pertinent provisions of federal law codified in regulations at 21 CFR --610.46 - 610.47 and 42 CFR --482.27(c). "Lookback" is the process of tracing products from donors who subsequently test positive for an infectious disease marker (e.g., HIV, HBV, HCV, HTLV) or report a CJD/vCJD risk.
5. Hospital is responsible for the following Look back requirements:
6. Quarantine.
In accordance with Regulatory Guidance, Hospital shall determine the disposition of and either (a) discard or (b) quarantine all potentially Infectious Blood or Blood Products in inventory. Hospital is responsible for discarding or releasing any units held in quarantine.
7. Hospital shall not return to CONTRACTOR any Potentially Infectious Blood or Blood Products. If Hospital chooses to discard such units, Hospital may, in accordance with then-applicable CONTRACTOR policy, make specific written request to CONTRACTOR for credit for such discarded units.
8. Physician/Patient Notification.
Hospital shall take all steps necessary to comply with applicable Regulatory Guidance, including, without limit, the pertinent provisions for timely physician and patient notification set forth in 42 CFR 482.27(c)(4) - (c)(8).
(a) Hospital Responsibility. If Hospital contracts with a third party for performance of notification, testing and counseling, Hospital remains responsible for notification and referral of patients.
(b)Confidentiality and Recordkeeping
Each party shall establish and comply with policies and procedures for notification, documentation and recordkeeping in conformance with federal laws, including, without limit, requirements for ensuring confidentiality and maintaining and managing medical records. [For CONTRACTOR, see 21 CFR 606.100 and 21 CFR 606.160; for Hospital, see 42 CFR 482.27(c)(7).]
SECTION II - THERAPEUTICS APHERISIS SERVICES
The contractor agrees to provide in-house and outpatient therapeutic apheresis as needed when such physician's order is received. The contractor warrants that all therapeutic apheresis services shall be provided by qualified and experienced personnel who shall be Registered Nurses or Licensed Practical Nurses. For purposes of this Agreement, all such personnel shall hereinafter be referred to as "Apheresis Nurses".
The contractor shall provide for all equipment and disposables necessary to accomplish therapeutic apheresis procedures once vascular access has been established by VA personnel. If blood components or albumin are required, they will be provided by the VA. Portable equipment allows the Apheresis Nurses to perform therapeutic procedures at the patient's bedside.
Documentation of the therapeutic procedure is provided by the contractor. Documentation is scanned into the patient's chart by VA staff. The VA medical staff will provide consultation services as part of the procedure. The VA medical staff will formulate a therapeutic plan including volumes to be exchanged or treated, replacement solutions, frequency and number of procedures, lab tests to monitor response, and care for any adverse event directly related to the therapeutic apheresis procedure. The VA will maintain and retain responsibility for any patient undergoing therapeutic apheresis.
SECTION III - OTHER:
1. THE JOINT COMMISSION, VHA (
a. The contractor must perform the required work in accordance with
b. The contractor shall comply with the policies of VA in accordance with Hospital Policy Memorandum No. 113-2 attached and any subsequent revisions thereof.
c. Contractor agrees to maintain the minimum acceptable service, reporting systems and quality control as specified herein. Failure to comply with the specified terms and conditions and/or adverse reports from external monitoring agencies, which indicate poor quality of care as addressed in paragraph a and b above and any other noncompliance issues, are grounds for termination of the contract. Immediate (within 24 hours) notification shall be given to VA regarding adverse reports and action by a regulatory agency.
d. The requirements of the contract may be changed by written modification to this contract. All modifications will be approved and prepared by the VA Contracting Officer.
e. The contractor shall furnish the supplies specified in this contract to VA when authorized by the Contracting Officer's Representative (COR) in accordance with attached Contract Monitoring Procedures.
2. TERM OF CONTRACT:
a. This contract is for one year - 6 months with two (2) quarter options. If exercised, option years will be on the same months and days of the four (4) following years.
b. The contractor is required to begin providing supplies and services in accordance with the schedule, depending upon the needs of the facility.
3. QUALIFICATIONS:
a. The contractor shall have a blood bank currently registered and/or licensed with the
b. The VA will inspect the establishment, facilities, business reputation, and other qualifications of any contractor and reserves the right to reject any offer, irrespective of price, that shall be administratively determined by the Contracting Officer to be lacking in any of the essentials judged necessary to assure acceptable standards of performance.
c. Any sub-contractor utilized by the contractor for the provision of supplies required under this contract must meet the same qualifications specified herein for the contractor. The contractor must obtain approval from the Contracting Officer for any sub-contractor to be utilized for the provision of supplies required under this contract.
d. Thirty (30) days prior to contract expiration date, the contractor shall certify in writing to the Contracting Officer that all licenses and registrations of personnel employed under this contract are valid and current and shall be renewed as necessary during any option period.
4. PERSONNEL POLICY:
The Contractor shall assume full responsibility for the protection of its personnel furnishing services under this contract, in accordance with the personnel policy of the Contractor, such as providing worker's compensation, professional liability insurance, health examinations, income tax withholding, and social security payments. The parties agree that the contractor, its employees, agents, and subcontractors shall not be considered VA employees for any purpose.
5. CONTRACT MONITORING PROCEDURES:
Any incidents of contractor noncompliance as evidenced by these monitoring procedures shall be forwarded immediately to the Contracting Officer.
6. CONFIDENTIALITY:
a. The VA will provide the contractor with access to pertinent patient medical information, within the existing privacy rules and regulations. Contractor shall ensure the confidentiality of all patient information and shall be held liable in the event of the breach of confidentiality.
b. The contract is subject to the Privacy Act of 1974. See 'Addendum to 52.212-4 - Contract Terms and Conditions - Commercial Items' for the full test of Privacy Act clauses. The Contractor is not authorized to release any VA medical record information. The VA is the sole entity authorized to release this information upon written request from the patient.
7. PAYMENTS AND INVOICING:
a. All invoices will be paid monthly in arrears upon receipt of invoice. Each invoice must indicate the month in which the items were delivered and the appropriate obligation number.
b. Invoices shall be matched against VA bill validation report to verify supplies were delivered in accordance with the contract.
c. The VA will review the invoice against its record. VA will notify the contractor of invoice discrepancies. Upon the resolution of the discrepancies, contractor shall submit a revised invoice; the VA will verify revised invoice and make payment accordingly.
8. PERFORMANCE STANDARDS:
Performance standards define desired services. The Government performs surveillance to determine if the contractor exceeds, meets or does not meet these standards.
The Performance Requirements Summary Matrix, paragraph in the Performance Work Statement (PWS), includes performance standards. The Government will use these standards to determine contractor performance and will compare contractor performance to the Acceptable Quality Level (AQL).
Task ID Indicator Standard Acceptable Quality Level Method of Surveillance Incentive
Quality of Services 1 Temperature
Monitoring of Blood Products
Proper temperature of blood products during shipping and storage will be monitored and documented. 100% compliance Review of temperature records and graphs Exercise of Option Period and past performance
2 Accuracy in documenting receipt, inspection and/or screening of blood products received Quality of each Blood Product, (includes labeling) must be documented upon receipt 100% compliance
Review of Blood Product inspection, assessment, rejection documents and records Exercise of Option Period and past performance
4. Attendance at the monthly Transfusion Committee meeting A technical and medical representative are required to attend the monthly meeting. One representative or both are required to attend 75% of the meetings. Transfusion Committee meeting minutes. Exercise of Option Period and past performance
5 Accuracy of Billing Invoices must accurately reflect goods and services provided by the contractor 100% accuracy
Billing discrepancies must be corrected within 90 days. Transaction Activity Reports compared to invoices. Exercise of Option Period and favorable past performance
9. INCENTIVES:
The Government will document/report contractor performance and potentially exercise option periods as an incentive. Incentives will be based on meeting, exceeding or not meeting performance standards.
10. METHODS OF QA SURVEILLANCE:
Various methods exist to monitor performance. The Contracting Officer's Representative (COR) will use the surveillance methods listed below in the administration of this QASP.
a. DIRECT OBSERVATION. (Can be performed periodically or through 100% surveillance.)
b. PERIODIC INSPECTION. (Evaluates outcomes on a periodic basis. Inspections may be scheduled [Daily, Weekly, Monthly, Quarterly, or annually] or unscheduled, as required.)
c. USER SURVEY. (Combines elements of validated user complaints and random sampling. Random survey is conducted to solicit user satisfaction. It may also generate inspections and sampling.)
d. PERIODIC SAMPLING. (Variation of random sampling. However, sample is only taken when a problem/deficiency is suspected. Sample results are applicable only for the specific work inspected. Since sample is not entirely random, it cannot be applied to total activity performance.)
11. DOCUMENTING PERFORMANCE:
a. ACCEPTABLE PERFORMANCE
The Government will document positive performance. Any report may become a part of the supporting documentation for any contractual action.
b. UNACCEPTABLE PERFORMANCE
When unacceptable performance occurs, the COR will inform the contractor. This will normally be in writing unless circumstances necessitate verbal communication. In any case the COR will document the discussion and place it in the COR file.
When the COR determines formal written communication is required, the COR will prepare a Contract Discrepancy Report (CDR), and present it to the contractor's program manager.
The contractor shall acknowledge receipt of the CDR in writing. The CDR will specify if the contractor is required to prepare a corrective action plan to document how the contractor shall correct the unacceptable performance and avoid a recurrence. The CDR will also state how long after receipt the contractor has to present this corrective action plan to the COR. The Government will review the contractor's corrective action plan to determine acceptability.
Any CDRs may become a part of the supporting documentation for any contractual action deemed necessary by the CO.
13. FREQUENCY OF MEASUREMENT:
a. Frequency of Measurement.
During contract performance, the COR will periodically analyze whether the negotiated frequency of surveillance is appropriate for the work being performed.
b. Frequency of Performance Assessment Meetings.
The COR will meet with the contractor monthly to assess performance and will provide a written assessment.
14. OTHER/APPLICABLE POLICIES AND REGULATIONS:
The Contractor shall perform in accordance with policies and procedures set forth in VHA Handbook 1106.01, Pathology and Laboratory Medicine Service Procedures the handbook can be located at the following web address: www.va.gov/vhapublications/viewpublication.asp pub_id=1779
HHS/OIG: To ensure that the individuals performing under the contract have not engaged in fraud or abuse regarding Sections 1128 and 1128A of the Social Security Act regarding federal health care programs, the contractor is required to check the Health and Human Service -
"Contractor shall provide health care to patients seeking such care from or through VA. As such, contractor is considered part of the Department health activity for purposes of the following statues and the VA regulations implementing these statues: the Privacy Act, 5.U.S.C. '' 552a, and 38 U.S.C. -'s 5701, 7705 and 7332. Contractor and its employees may have access to VA patient medical records to the extent necessary for the contract or to perform this contract. Notwithstanding any other provision of this contract, contractor and its employees shall disclose patient treatment records only pursuant to explicit disclosure authority for VA. Contractor and its employees are subject to the penalties and liabilities provided statutes and regulations for unauthorized disclosures of such records and their contents." "Records created by the contractor in the course of treating VA patients under this agreement are the property of the VA and shall not be accessed, released, transferred or destroyed except in accordance with applicable federal law and regulations." Upon the expiration of this contract or termination of the contract, the contractor shall promptly provide the VA with the individually identified VA patient treatment records."
HIPAA COMPLIANCE: "Contractor must adhere to the provisions of Public Law 104-191, Health Insurance Portability and Accountability Act (HIPAA) of 1996 and the National Standards to Protect the Privacy and Security of Protected Health Information (PHI). A business associate agreement is not required in this case.
CONTRACTING OFFICER' REPRESENTATIVE:
All work coordination shall be made through the Contracting Officer's Representative ( COR). The Contractor shall be provided a copy of the letter of delegation, authorizing the COR at the commencement of the term of this agreement. No other person shall be authorized to act in such capacity unless appointed in writing by the Contracting Officer (CO). The COR will be the VA official responsible for verifying contract compliance. After contract award, any incidents of contractor noncompliance as evidenced by the monitoring procedures shall be forwarded immediately to the CO.
SERVICES CHARGES TO VA BENEFICIARIES:
VA beneficiaries shall not under any circumstances be charged nor their insurance companies charged for services rendered by the contractor even if VA does not pay for those services. This provision shall survive the termination or ending of the contract
REQUIRED REGISTRATION WITH CONTRACTOR PERFORMANCE ASSESSMENT SYSTEM (CPARS):
(a) As prescribed in Federal Acquisition Regulation (FAR) Part 42.15, the
(b) Each contractor whose contract award is estimated to exceed
(c) For contracts with a period of one year or less, the contracting officer will perform a single evaluation when the contract is complete. For contracts exceeding one year, the contracting officer will evaluate the contractor's performance annually. Interim reports will be filed each year until the last year of the contract, when the final report will be completed. The report shall be assigned in CPARS to the contractor's designated representative for comment. The contractor representative will have thirty days to submit any comments and re-assign the report to the VA contracting officer.
(d) Failure to have a current registration in the CPARS database, or to re-assign the report to the VA contracting officer within those thirty days, will result in the Government's evaluation being placed on file in the database with a statement that the contractor failed to respond.
(vii) The commodity is to be delivered on or before a date to be determined
(viii) Provision 52.212-1, Instructions to Offerors - Commercial (
" Addendum to FAR 52.212-1 Instructions to Offerors - Commercial Items;
*- 52.203-11 Certification and Disclosure regarding payments to Influence certain Federal Transactions (
*- 52.204-5 Women-Owned Business (Other Than Small Business)
*- 52.212-1 Instructions to Offerors - Commercial Items (APR 2014);
*- 52.225-25 Prohibition on Contracting with entities engaging in certain activities or transactions relating to
" 52.211-6 Brand Name or Equal (AUG 1999);
" 52.252-1
(ix) Provision 52.212-2, Evaluation - Commercial Items (
(x) It is advised that Offerors include a completed copy of the provision at 52.212-3 Offeror Representation and Certification - Commercial Items (
(xi) Clause 52.212-4, Contract Terms and Conditions - Commercial Items, applies to this acquisition. All offers must include a completed copy of this provision. All Offers must either be accompanied by Representations and Certifications or the offeror must be currently registered in ORCA at website https://orca.bpn.gov/ Clauses and provisions included are:
" Addendum to FAR 52.212-4 Contract and Conditions - Commercial Items;
*- 52.202-1 Definitions (NOV 2013);
*- 52.203-3 Gratuities (APR 1984);
*- 52.203-5 Covenant Against Contingent Fees;
*- 52.203-6 Restrictions on Subcontractor Sales to the Government (SEP 2006);
*- 52.203-7 Anti-Kickback Procedures
*- 52.203-12 Limitation on payments to influence certain federal transactions (OCT 2010);
*- 52.204-7 System for award management (
*- 52.212-2 Evaluation - Commercial Items
*- 52.212-3 Offeror Representations and Certifications - Commercial items (
*- 52.216-24 Limitation of Liability
*- 52.216-25 Contract Definitization
*- 52.217-9 Option to extend term of the contract
*- 52.222-20 Walsh Healey Public Contracts Act
*- 52.232-1 Payments (APR 1984);
*- 52.232-18 Availability of Funds
*- 52.232-8 Discounts for prompt payment (FEB 2002);
*- 52.232-17 Interest (MAY 2014);
*- 52.233-3 Protest After Award
*- 52.233-4 Applicable Law for Breach of Contract Claim (OCT 2004);
*- 52.243-1 Changes -Fixed Price (AUG 1987);
*- 52.244-6 Subcontracts for Commercial Items (APR 2015);
*- 52.249-1 Termination for the Convenience of the Government (APR 1984);
" 52.212-4 Contract Terms and Conditions - Commercial items (SEP 2013);
" 52.252-2
" VAAR 852.252-70 Solicitation Provisions or
*- 852.203-70
*- 852.211-72 Technical Industry Standards
*- 852.215-70 SDVOSB and VOSB Evaluation Factors (DEC 2009);
*- 852.215-71 Evaluation Factor Commitments (DEC 2009);
*- 852.216-70 Estimated Quantities
*- 852.237-70 Contractor Responsibility
*- 852.246-71 Inspection (JAN 2008);
*- 852.233-70 Protest Content/Alternative Dispute Resolution (JAN 2008);
*- 852.233-71 Alternate Protest Procedure (JAN 1998);
" VAAR 852.246-70 Guarantee (JAN 2008);
(xii) 52.212-5, Contract Terms and Conditions Required Implementing Statutes or Executive Orders - Commercial Items, applies to this acquisition. The following clauses are incorporated by reference:
" 52.222-50, Combating Trafficking in Persons (
" Alternate I (
" 52.233-3, Protest After Award (
" 52.233-4, Applicable Law for Breach of Contract Claim (
" 52.209-10, Prohibition on Contracting with Inverted Domestic Corporations (
" 52.219-28, Post Award Small Business Program Representation (
" 52.222-3, Convict Labor (
" 52.222-19, Child Labor-Cooperation with Authorities and Remedies (
" 52.222-21, Prohibition of Segregated Facilities (Feb 1999);
" 52.222-26, Equal Opportunity (
" 52.222-36, Affirmative Action for Workers with Disabilities (
" 52.223-18, Encouraging Contractor Policies to Ban Text Messaging While Driving (AUG 2011);
" 52.225-1,
" 52.225-13, Restrictions on Certain Foreign Purchases (
" 52.232-34, Payment by Electronic Funds Transfer-Other than System for Award Management (
(xiii) NA.
(xiv) NA.
(xv) The RFQ is due on
(xvi) For further information contact Debra c. Flanders via phone (407) 646-4016, facsimile (407) 646-4000, or
e-mail: [email protected].
Contracting Office Address:
Point of contact(s):
Link/URL: https://www.fbo.gov/spg/VA/OrVAMC/Or675VAMC/VA24815Q0634/listing.html



Advisor News
- Advisors must lead the policy risk conversation
- Gen X more anxious than baby boomers about retirement
- Taxing trend: How the OBBBA is breaking the standard deduction reliance
- Why advisors can’t afford to delay succession planning
- 6 in 10 Americans struggle with financial decisions
More Advisor NewsAnnuity News
- CT commissioner: 70% of policyholders covered in PHL liquidation plan
- ‘I get confused:’ Regulators ponder increasing illustration complexities
- Three ways the Corebridge/Equitable merger could shake up the annuity market
- Corebridge, Equitable merge to create potential new annuity sales king
- LIMRA: Final retail annuity sales total $464.1 billion in 2025
More Annuity NewsHealth/Employee Benefits News
- Advocates call for hearing about Geisinger-Risant insurance condition change request
- Tucson Speaks Out: April 5
- El Rio taps experienced leader to oversee transition from North Country HealthCare to Elk Ridge
- Red ink at Minnesota Blue Cross spells more Medicare Advantage troubles ahead
- MEDICAID COST-SHARING LIMITATIONS AMENDED, ADVANCED
More Health/Employee Benefits NewsLife Insurance News
- WHAT THEY ARE SAYING: KATHLEEN COULOMBE JOINS ACU AS CHIEF ADVOCACY OFFICER
- A-CAP Appoints Kirk Cullimore as President of Sentinel Security Life
- Nationwide enters centennial year stronger than ever
- AM Best Affirms Credit Ratings of Mutual of Omaha Insurance Company and Its Subsidiaries
- AM Best Affirms Credit Ratings of CMB Wing Lung Insurance Company Limited
More Life Insurance News